Skip to main content
NANOSONICS LIMITED logo

NANOSONICS LIMITED — Investor Relations & Filings

Ticker · NAN ISIN · AU000000NAN9 LEI · 549300XUBCM70BRANN81 ASX Manufacturing
Open in API
Filings indexed 1,049 across all filing types
Latest filing 2009-08-20 Annual Report
Country AU Australia
Listing ASX NAN

About NANOSONICS LIMITED

https://www.nanosonics.com.au

Nanosonics Limited is a medical technology company specializing in the development and commercialization of infection prevention solutions. The company's flagship product, the trophon system, provides automated high-level disinfection (HLD) for ultrasound probes. Utilizing a proprietary hydrogen peroxide mist technology, the trophon device ensures consistent and effective disinfection of both the probe handle and shaft, addressing the risks of cross-contamination in clinical settings. The system is designed to integrate into diagnostic workflows, offering a faster and more environmentally sustainable alternative to traditional manual chemical soaking methods. Nanosonics continues to expand its portfolio with digital traceability tools and audit-ready reporting software to enhance compliance and patient safety across global healthcare facilities.

Recent filings

Filing Released Lang Actions
2009 Results and 4E Statement 4 pages ?Kb
Annual Report Classification · 95% confidence The document is titled 'Nanosonics 2009 Annual Results' and includes detailed financial data for the year ended 30 June 2009, such as revenue, profit/loss, dividends, net tangible assets per share, and segment information. It references compliance with Australian Accounting Standards and includes notes about the audited Annual Report accompanying this announcement. The document also mentions the Auditor's Report and that the financial statements are audited without qualification. The presence of comprehensive financial statements, notes, and audit information indicates this is a full annual report rather than a brief announcement or summary. The document length (9576 characters) supports it being a substantive report. Therefore, the document fits the definition of an Annual Report (10-K equivalent). FY 2009
2009-08-20 English
2009 Annual Report 86 pages ?Kb
Annual Report Classification · 100% confidence The document is titled as an Annual Report for the Financial Year 2009, as indicated in the Chairman's letter and the detailed contents including company overview, directors' report, corporate governance statement, remuneration report, auditor's independence declaration, financial report, directors' declaration, and independent auditor's report. The length of the document is substantial (15,000 characters), and it contains comprehensive information about the company's operations, financials, governance, and audit reports. This matches the definition of an Annual Report (10-K) which covers company activity and full financial performance for the year. Therefore, the document is classified as an Annual Report (10-K).
2009-08-20 English
Change in Director`s interest - Founder options exercised 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, the nature of the interest, and the value of the transaction. This matches the definition of a Director's Dealing report, which involves reporting personal share transactions by company directors and executives (insider trades). The document length is 2859 characters, which is consistent with a detailed notice rather than a brief announcement or a full report. Therefore, the correct classification is Director's Dealing (DIRS).
2009-08-02 English
4C Statement for quarter and year ended 30 June 2009 4 pages ?Kb
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C QUARTERLY REPORT' and specifies the quarter ended as 30 June 2009. It contains detailed financial data including consolidated statement of cash flows, cash flow related to operating, investing, and financing activities, payments to directors, reconciliation of cash, and compliance statements. The length is over 6,000 characters, indicating it is a substantive report rather than a brief announcement. The presence of quarterly financial data and the term 'Quarterly Report' strongly indicates this is an Interim / Quarterly Report. The document is not a full annual report (10-K), nor is it a brief earnings release or a regulatory announcement. Therefore, the correct classification is Interim / Quarterly Report (IR). Q4 2009
2009-07-30 English
FDA and Regulatory update 1 page ?Kb
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 10th July 2009 from Nanosonics Limited, providing an update on regulatory approvals and FDA review status for a medical device product. It mentions receipt of FDA initial review notification and regulatory approval in Israel, as well as plans for US distributor appointments. The text is brief (2030 characters) and does not contain any financial data, detailed financial results, or comprehensive report content. It is an update on regulatory and FDA matters, not a full report or financial filing. It fits best as a Regulatory Filings (RNS) category, which covers general regulatory announcements and compliance updates that do not fit other specific categories.
2009-07-09 English
New shares issued, options granted 16 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is a detailed announcement from Nanosonics Limited regarding the issuance of new securities, including ordinary shares and options granted under employee share plans. It includes an Appendix 3B New Issue Announcement, which is a standard form used in Australian Securities Exchange (ASX) filings to notify the market of new securities issued by a company. The content focuses on the issuance of shares and options, terms of the securities, and compliance with ASX listing rules. There is no financial statement, earnings data, or management discussion of financial results. The document is not a report but an official announcement of new share issues and option grants. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2009-06-29 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.